open.spotify.com
Mar 17, 2026, 15:43
How Clinicians Navigate the Challenge of Balancing Clotting and Bleeding in CAD – Vasculearn Network
Vasculearn Network shared a post on LinkedIn:
“Antithrombotic therapy in coronary artery disease isn’t one-size-fits-all anymore.
Heather M. Johnson, Ty J. Gluckman and Davide Capodanno come together in the latest episode of Clot, Clot, Who’s There? to chat about how clinicians are navigating the everyday challenge of balancing clotting and bleeding risk.
From the evolving role of aspirin to P2Y12 monotherapy, dual pathway inhibition, and managing CAD with AFib, the conversation highlights a simple shift in thinking:
Less of ‘What should everyone get?’
More of ‘What’s right for the patient in front of me?’
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation